Wyeth was a bigger deal, but with Pfizer's payout ratio so high, there isn't much wiggle room for the dividend. In other ...

Grim revelations have surfaced from within the Department of Health and Human Services (HHS), exposing a culture of censorship surrounding critical discussions about the COVID-19 vaccine and its ...

Pfizer sell 508M stake in BioNTech through an overnight block trade, marking its exit from the COVID-19 vaccine partner's equity.

A BioNTech spokesperson downplayed the news, insisting that the two companies remain “close” and have a “strong collaboration ...

Move marks shift after years of mRNA collaboration that produced COVID-19 vaccine.

Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE , more than five years after both ...

(Reuters) - Pfizer Inc said on Thursday said that it will sell 54.7% of its stake in German drugmaker BioNTech SE, over five years after both firms formed an alliance that yielded a vaccine to combat ...

Mikael Dolsten, Pfizer's former research and development chief, has withdrawn his candidacy for Novo Nordisk's board, citing ...

Pfizer CEO says RFK Jr.'s appointment was not up to him, though he has found common ground with the vaccine skeptic.

Speaking at a conference this morning, Pfizer CEO Albert Bourla suggested that Metsera’s therapies could begin hitting the ...

Pfizer CEO Albert Bourla told Yahoo Finance that Pfizer has a "right to win" on the obesity drugs that have become a major ...

The US drugmaker is offering about 4.55 million American depositary receipts via an overnight block trade marketed between ...